Literature DB >> 20197143

Innate and acquired immune responses induced by recombinant Lactobacillus casei displaying flagellin-fusion antigen on the cell-surface.

Akinobu Kajikawa1, Shizunobu Igimi.   

Abstract

Bacterial flagellins are known as antigens that induce innate immune responses through TLR5 and boost immune responses in combination with other antigens. The aim of the present study was to determine the immunological properties of recombinant Lactobacillus casei producing flagellin and flagellin-fusion antigens in vitro and in vivo. Recombinant lactobacilli expressing Salmonella FliC and FliC fused to truncated SipC on the cell-surface were constructed. Fusion and non-fusion flagellin associated with L. casei retained the ability to induce IL-8 production by Caco-2 cells. Immunization of mice with these recombinant strains induced antigen-specific antibodies and cytokine production. The results showed that the outside epitope of the heterologous antigen was recognized more easily by the immune system than the inside epitope. The immune responses elicited by the Lactobacillus-associated antigens were mainly Th1 while that by the soluble antigen was Th2, although some of the responses were mixed. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20197143     DOI: 10.1016/j.vaccine.2010.02.077

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

Review 1.  Bioengineered probiotics, a strategic approach to control enteric infections.

Authors:  Mary Anne Roshni Amalaradjou; Arun K Bhunia
Journal:  Bioengineered       Date:  2013-01-17       Impact factor: 3.269

2.  Assessment of Lactobacillus gasseri as a candidate oral vaccine vector.

Authors:  Laura Stoeker; Shila Nordone; Sara Gunderson; Lin Zhang; Akinobu Kajikawa; Alora LaVoy; Michael Miller; Todd R Klaenhammer; Gregg A Dean
Journal:  Clin Vaccine Immunol       Date:  2011-09-07

Review 3.  Peptide-Based Vaccines for Tuberculosis.

Authors:  Wenping Gong; Chao Pan; Peng Cheng; Jie Wang; Guangyu Zhao; Xueqiong Wu
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

Review 4.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

5.  Characterization of pro-inflammatory flagellin proteins produced by Lactobacillus ruminis and related motile Lactobacilli.

Authors:  B Anne Neville; Brian M Forde; Marcus J Claesson; Trevor Darby; Avril Coghlan; Kenneth Nally; R Paul Ross; Paul W O'Toole
Journal:  PLoS One       Date:  2012-07-10       Impact factor: 3.240

6.  Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.

Authors:  Orit Gat; James E Galen; Sharon Tennant; Raphael Simon; William C Blackwelder; David J Silverman; Marcela F Pasetti; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2011-11-01

Review 7.  Development of recombinant vaccines in lactobacilli for elimination of salmonella.

Authors:  Akinobu Kajikawa; Shizunobu Igimi
Journal:  Biosci Microflora       Date:  2011-11-17

8.  Mucosal Immunogenicity of Genetically Modified Lactobacillus acidophilus Expressing an HIV-1 Epitope within the Surface Layer Protein.

Authors:  Akinobu Kajikawa; Lin Zhang; Alora LaVoy; Sara Bumgardner; Todd R Klaenhammer; Gregg A Dean
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

9.  A recombinant chimera comprising the R1 and R2 repeat regions of M. hyopneumoniae P97 and the N-terminal region of A. pleuropneumoniae ApxIII elicits immune responses.

Authors:  Seung Heon Lee; Seungwoo Lee; Chanhee Chae; Doug-Young Ryu
Journal:  BMC Vet Res       Date:  2014-02-18       Impact factor: 2.741

Review 10.  Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery.

Authors:  Ivan Y C Lin; Thi Thu Hao Van; Peter M Smooker
Journal:  Vaccines (Basel)       Date:  2015-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.